You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ASDAS inactive disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematological Parameters in Axial Spondyloarthritis

Recruiting
  • Ankylosing Spondylitis
  • Systemic inflammatory index
  • +4 more
  • İzmir, Turkey
  • +1 more
Jan 15, 2023

Non-radiographic Axial Spondyloarthritis Trial (Secukinumab, Placebo)

Not yet recruiting
  • Non-radiographic Axial Spondyloarthritis
  • (no location specified)
Nov 16, 2022

Crohn Disease Trial in New York (Placebo, Bacteriophage preparation)

Recruiting
  • Crohn Disease
  • Placebo
  • Bacteriophage preparation
  • New York, New York
    The Mount Sinai Hospital
Jan 6, 2023

Thyroid Eye Disease, Chronic (Inactive) Thyroid Eye Disease Trial in United States (TEPEZZA, Placebo)

Active, not recruiting
  • Thyroid Eye Disease
  • Chronic (Inactive) Thyroid Eye Disease
  • TEPEZZA
  • Placebo
  • Beverly Hills, California
  • +11 more
Nov 4, 2022

Non-Alcoholic Fatty Liver Disease Trial in Cairo (Cholecalciferol)

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Cairo, Egypt
    National hepatology and tropical medicine research institute
Nov 3, 2022

IBD Trial (Anorectal manometry)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Anorectal manometry
  • (no location specified)
Apr 22, 2022

IBP Criteria & Activity Scores in Patients With AxSpA

Completed
  • Axial Spondyloarthritis
  • Inflammatory Back Pain
    • Zagazig, Sharqia, Egypt
      Zagazig university
    Jan 24, 2023

    Parkinson Disease Trial (active subthalamic nucleus deep brain stimulation plus optimal drug therapy, inactive subthalamic

    Not yet recruiting
    • Parkinson Disease
    • active subthalamic nucleus deep brain stimulation plus optimal drug therapy
    • inactive subthalamic nucleus deep brain stimulation plus optimal drug therapy
    • (no location specified)
    Aug 23, 2023

    Restless Legs Syndrome, End Stage Renal Disease Trial (Ascorbic acid, Tocopherol, Placebo capsule)

    Not yet recruiting
    • Restless Legs Syndrome
    • End Stage Renal Disease
    • Ascorbic acid
    • +2 more
    • (no location specified)
    Aug 22, 2022

    Alzheimer Trial in Saint Louis (Lemborexant 25 mg, Placebo)

    Recruiting
    • Alzheimer Disease
    • Lemborexant 25 mg
    • Placebo
    • Saint Louis, Missouri
      Washington University School of Medicine
    Feb 16, 2023

    Sleep, Alzheimer Trial in Saint Louis (Suvorexant 20 mg, Placebo)

    Recruiting
    • Sleep
    • Alzheimer Disease
    • Suvorexant 20 mg
    • Placebo
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 15, 2022

    Alzheimer's Disease Trial in New Haven, West Bend (BMS-984923, Placebo)

    Recruiting
    • Alzheimer's Disease
    • New Haven, Connecticut
    • +1 more
    Mar 27, 2023

    Schizophrenia, Schizo Affective Disorder, Bipolar Disorder Trial in Ann Arbor (tDCS, BrainHQ)

    Recruiting
    • Schizophrenia
    • +2 more
    • tDCS (Active)
    • +2 more
    • Ann Arbor, Michigan
      University of Michigan
    Nov 4, 2022

    Diarrhea, Gastrointestinal Infection, Respiratory Viral Infection Trial in Philadelphia (Active UV Device, Inactive UV Device)

    Recruiting
    • Diarrhea
    • +3 more
    • Active UV Device
    • Inactive UV Device
    • Philadelphia, Pennsylvania
      Temple University
    Jul 29, 2022

    Cardiovascular Risk Factor, Prediabetes, Overweight and Obesity Trial in Beaver Falls, Pittsburgh (The Physical Activity for The

    Completed
    • Cardiovascular Risk Factor
    • +3 more
    • The Physical Activity for The Heart (PATH) intervention
    • Be Active Your Way Booklet
    • Beaver Falls, Pennsylvania
    • +1 more
    Oct 6, 2022

    Investigate Clinical REsponses in Ankylosing Spondylitis

    Completed
    • Ankylosing Spondylitis (AS)
      • Hualien City, Taiwan
        Hualien Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation
      Nov 18, 2021

      Multiple Sclerosis Trial in France (DMT withdrawal, DMT continuation)

      Recruiting
      • Multiple Sclerosis
      • DMT withdrawal
      • DMT continuation
      • Angers, France
      • +22 more
      Mar 25, 2022

      Gastrointestinal Infection, Respiratory Viral Infection Trial in Philadelphia (Active household UV water treatment device,

      Active, not recruiting
      • Gastrointestinal Infection
      • Respiratory Viral Infection
      • Active household UV water treatment device
      • Inactive household UV water treatment device
      • Philadelphia, Pennsylvania
        Temple University
      Jul 29, 2022

      End Stage Renal Disease Trial in Nashville (dietary supplement, drug, behavioral)

      Not yet recruiting
      • End Stage Renal Disease
      • CoQ10
      • +3 more
      • Nashville, Tennessee
        Vanderbilt University Medical Center-GCRC
      Jun 13, 2022

      Cardiovascular Diseases, Hypertension Trial in San Francisco (Losartan, Placebo)

      Recruiting
      • Cardiovascular Diseases
      • Hypertension
      • San Francisco, California
        San Francisco Veterans' Affairs Medical Center
      Apr 29, 2022

      Assess Disease Activity in Adult Ankylosing Spondylitis Who

      Recruiting
      • Radiographic Axial Spondylarthritis (r-axSpA)
      • Ulm, Baden-Wuerttemberg, Germany
      • +69 more
      Aug 8, 2022

      Axial Spondyloarthritis Trial (Tapered doses of TNFi, Standard dose of TNFi)

      Recruiting
      • Axial Spondyloarthritis
      • Tapered doses of TNFi
      • Standard dose of TNFi
      • Toronto, Ontario, Canada
        University Health Network - Toronto Western Hospital
      Nov 21, 2022

      Coronary Artery Disease, Myocardial Infarction Trial in Scottsdale, Rochester (Pulsed electromagnetic field therapy (PEMF),

      Recruiting
      • Coronary Artery Disease
      • Myocardial Infarction
      • Pulsed electromagnetic field therapy (PEMF)
      • Inactive Pulsed electromagnetic field therapy (PEMF)
      • Scottsdale, Arizona
      • +1 more
      May 25, 2022

      Ankylosing Spondylitis Trial in United States (150 mg open-label secukinumab, 150 mg double-blinded secukinumab, 300 mg

      Completed
      Has Results
      • Ankylosing Spondylitis
      • 150 mg open-label secukinumab
      • +2 more
      • Jonesboro, Arkansas
      • +64 more
      Apr 27, 2022

      Borderline Personality Disorder Trial in Melbourne (NMDA receptor antagonist (active drug), Lactose packed capsule

      Recruiting
      • Borderline Personality Disorder
      • NMDA receptor antagonist (active drug)
      • Lactose packed capsule (inert/inactive arm)
      • Melbourne, Victoria, Australia
        Monash Alfred Psychiatry Research Centre
      Sep 27, 2022